Arrow - Lamotrigine New Zealand - English - Medsafe (Medicines Safety Authority)

arrow - lamotrigine

teva pharma (new zealand) limited - lamotrigine 200mg - chewable/dispersible tablet - 200 mg - active: lamotrigine 200mg excipient: colloidal silicon dioxide as silica - colloidal anhydrous croscarmellose sodium magnesium stearate mannitol microcrystalline cellulose povidone purified talc purified water ribes nigrum saccharin sodium - epilepsy adults (over 12 years of age) arrow - lamotrigine is indicated as adjunctive therapy in the treatment of epilepsy, for partial seizures and generalised seizures, including tonic-clonic seizures and the seizures associated with lennox-gastaut syndrome. children (2 to 12 years of age) arrow - lamotrigine is indicated as adjunctive therapy in the treatment of epilepsy, for partial seizures and generalised seizures including tonic-clonic seizures and the seizures associated with lennox-gaustaut syndrome. bipolar disorder (adults 18 years of age and over) arrow - lamotrigine is indicated for the prevention of mood episodes in patients with bipolar disorder, predominantly by preventing depressive episodes.

Arrow - Lamotrigine New Zealand - English - Medsafe (Medicines Safety Authority)

arrow - lamotrigine

teva pharma (new zealand) limited - lamotrigine 25mg; lamotrigine 25mg - chewable/dispersible tablet - 25 mg - active: lamotrigine 25mg excipient: colloidal silicon dioxide as silica - colloidal anhydrous croscarmellose sodium magnesium stearate mannitol microcrystalline cellulose povidone purified talc purified water ribes nigrum saccharin sodium active: lamotrigine 25mg excipient: colloidal silicon dioxide as silica - colloidal anhydrous croscarmellose sodium magnesium stearate mannitol microcrystalline cellulose povidone purified talc purified water ribes nigrum saccharin sodium - epilepsy adults (over 12 years of age) arrow - lamotrigine is indicated as adjunctive therapy in the treatment of epilepsy, for partial seizures and generalised seizures, including tonic-clonic seizures and the seizures associated with lennox-gastaut syndrome. children (2 to 12 years of age) arrow - lamotrigine is indicated as adjunctive therapy in the treatment of epilepsy, for partial seizures and generalised seizures including tonic-clonic seizures and the seizures associated with lennox-gaustaut syndrome. bipolar disorder (adults 18 years of age and over) arrow - lamotrigine is indicated for the prevention of mood episodes in patients with bipolar disorder, predominantly by preventing depressive episodes.

Arrow - Lamotrigine New Zealand - English - Medsafe (Medicines Safety Authority)

arrow - lamotrigine

teva pharma (new zealand) limited - lamotrigine 2mg - chewable/dispersible tablet - 2 mg - active: lamotrigine 2mg excipient: colloidal silicon dioxide as silica - colloidal anhydrous croscarmellose sodium magnesium stearate mannitol microcrystalline cellulose povidone purified talc purified water ribes nigrum saccharin sodium - epilepsy adults (over 12 years of age) arrow - lamotrigine is indicated as adjunctive therapy in the treatment of epilepsy, for partial seizures and generalised seizures, including tonic-clonic seizures and the seizures associated with lennox-gastaut syndrome. children (2 to 12 years of age) arrow - lamotrigine is indicated as adjunctive therapy in the treatment of epilepsy, for partial seizures and generalised seizures including tonic-clonic seizures and the seizures associated with lennox-gaustaut syndrome. bipolar disorder (adults 18 years of age and over) arrow - lamotrigine is indicated for the prevention of mood episodes in patients with bipolar disorder, predominantly by preventing depressive episodes.

Arrow - Lamotrigine New Zealand - English - Medsafe (Medicines Safety Authority)

arrow - lamotrigine

teva pharma (new zealand) limited - lamotrigine 50mg; lamotrigine 50mg - chewable/dispersible tablet - 50 mg - active: lamotrigine 50mg excipient: colloidal silicon dioxide as silica - colloidal anhydrous croscarmellose sodium magnesium stearate mannitol microcrystalline cellulose povidone purified talc purified water ribes nigrum saccharin sodium active: lamotrigine 50mg excipient: colloidal silicon dioxide as silica - colloidal anhydrous croscarmellose sodium magnesium stearate mannitol microcrystalline cellulose povidone purified talc purified water ribes nigrum saccharin sodium - epilepsy adults (over 12 years of age) arrow - lamotrigine is indicated as adjunctive therapy in the treatment of epilepsy, for partial seizures and generalised seizures, including tonic-clonic seizures and the seizures associated with lennox-gastaut syndrome. children (2 to 12 years of age) arrow - lamotrigine is indicated as adjunctive therapy in the treatment of epilepsy, for partial seizures and generalised seizures including tonic-clonic seizures and the seizures associated with lennox-gaustaut syndrome. bipolar disorder (adults 18 years of age and over) arrow - lamotrigine is indicated for the prevention of mood episodes in patients with bipolar disorder, predominantly by preventing depressive episodes.

Arrow - Lamotrigine New Zealand - English - Medsafe (Medicines Safety Authority)

arrow - lamotrigine

teva pharma (new zealand) limited - lamotrigine 5mg; lamotrigine 5mg - chewable/dispersible tablet - 5 mg - active: lamotrigine 5mg excipient: colloidal silicon dioxide as silica - colloidal anhydrous croscarmellose sodium magnesium stearate mannitol microcrystalline cellulose povidone purified talc purified water ribes nigrum saccharin sodium active: lamotrigine 5mg excipient: colloidal silicon dioxide as silica - colloidal anhydrous croscarmellose sodium magnesium stearate mannitol microcrystalline cellulose povidone purified talc purified water ribes nigrum saccharin sodium - epilepsy adults (over 12 years of age) arrow - lamotrigine is indicated as adjunctive therapy in the treatment of epilepsy, for partial seizures and generalised seizures, including tonic-clonic seizures and the seizures associated with lennox-gastaut syndrome. children (2 to 12 years of age) arrow - lamotrigine is indicated as adjunctive therapy in the treatment of epilepsy, for partial seizures and generalised seizures including tonic-clonic seizures and the seizures associated with lennox-gaustaut syndrome. bipolar disorder (adults 18 years of age and over) arrow - lamotrigine is indicated for the prevention of mood episodes in patients with bipolar disorder, predominantly by preventing depressive episodes.